Italy Infectious Disease Diagnostics Market (2025-2030)
The Italy Infectious Disease Diagnostics Market was valued at $537.6 Million in 2025 and projected to reach to $822.9 Million by 2030, representing a compound annual growth rate of 8.9%. Italy's infectious disease diagnostics market is positioned for steady growth through 2030, supported by modernization of healthcare facilities and increased government spending on diagnostic infrastructure.
Italy Infectious Disease Diagnostics Market Trends and Insights
- This growth trajectory reflects Italy's strengthening healthcare infrastructure and increasing investment in diagnostic capabilities across the country.
- Italy's market expansion is driven by rising prevalence of infectious diseases, aging population demographics, and enhanced regulatory support for advanced diagnostic technologies. The Italian market benefits from strong healthcare spending and a well-established network of diagnostic laboratories and hospitals.
- Italy's commitment to modernizing its healthcare system has accelerated adoption of rapid diagnostic tests and molecular platforms.
- Between 2025 and 2030, Italy is expected to see significant integration of point-of-care testing and automated diagnostic systems, positioning the country as a key player in Europe's infectious disease diagnostics sector..
Key Market Statistics
- CAGR (2025-2030) 8.9% CAGR
- Market Size, 2025 ~USD 537.6 Million
- Forecast, 2030 ~USD 822.9 Million
- Country Italy
Italy Infectious Disease Diagnostics Market Overview
Market Valuation Growth :
Italy's infectious disease diagnostics market is valued at $537.6 million in 2025 and is projected to reach $822.9 million by 2030, demonstrating robust expansion in the Italian healthcare sector.
Strong CAGR Performance :
The Italian market is growing at a compound annual growth rate of 8.9% from 2025 to 2030, slightly below the global average of 9.7%, reflecting steady but measured market development.
Healthcare Infrastructure Investment :
Italy's strengthening healthcare infrastructure and increased diagnostic capabilities are driving market expansion, with enhanced investment in laboratory facilities and testing technologies across the country.
Rising Disease Prevalence :
Growing prevalence of infectious diseases in Italy is fueling demand for advanced diagnostic solutions, creating opportunities for market players to expand their product portfolios and service offerings.
Italy Infectious Disease Diagnostics Market Dynamics
- The Italian healthcare system's emphasis on early disease detection and prevention is driving adoption of advanced diagnostic technologies.
- Regional healthcare initiatives and European Union healthcare directives are further accelerating market development.
- The market will benefit from technological advancements in molecular diagnostics, immunoassays, and point-of-care testing solutions tailored to Italian healthcare providers' needs..
Related Ecosystem
In Vitro Diagnostics
Medical Devices
Key Takeaways
- Italy's infectious disease diagnostics market will grow from $537.6M (2025) to $822.9M (2030) at an 8.9% CAGR.
- Italy's aging population and rising infectious disease prevalence are primary growth catalysts for diagnostic demand.
- Italy is investing heavily in molecular and rapid diagnostic technologies to modernize its healthcare infrastructure.
- Italy's well-established laboratory network positions it as a competitive hub for infectious disease diagnostics in Europe.
Infectious Disease Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | MOSQUITO-BORNE DISEASES (Disease Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 9.7% from 2025 to 2030 |
| Largest Segment | LABORATORY TESTING (Type Of Testing) |
| Market Size Base Year (Billions) | ~USD 26.56 (2025) |
| Revenue Forecast (Billions) | ~USD 42.2 (2030) |
| Segments Covered | Product & Service, Type Of Testing, Sample Type, Disease Type, Type, Technology |
Italy Infectious Disease Diagnostics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents, Kits, And Consumables
- Software & Services
By Type Of Testing
- Laboratory Testing
- Poc Testing
By Sample Type
- Blood, Serum, And Plasma
- Other Sample Types
- Urine
By Disease Type
- Chlamydia Trachomatis
- Hepatitis
- Hiv
- Hospital-Acquired Infections
- Hpv
- Influenza
- Mosquito-Borne Diseases
- Neisseria Gonorrhea
- Other Infectious Diseases
- Syphilis
- Tuberculosis
By Type
- Hepatitis B
- Hepatitis C
- Other Hepatitis Diseases
By Technology
- Clinical Microbiology
- Dna Microarray
- Dna Sequencing & Next-Generation Sequencing
- Immunodiagnostics
- Isothermal Nucleic Acid Amplification Technology
- Other Technologies
- Polymerase Chain Reaction
Target Audience
- Diagnostic Device Manufacturers : Manufacturers need Italy-specific market data to assess market size, growth potential, and competitive positioning for launching or expanding diagnostic product lines in the Italian healthcare market.
- Healthcare Investment Firms : Investment professionals require detailed Italian market analysis to evaluate investment opportunities, identify high-growth segments, and assess the financial viability of diagnostic companies operating in Italy.
- Italian Healthcare Providers : Hospitals, laboratories, and diagnostic centers in Italy need market insights to benchmark their services, understand procurement trends, and plan capital investments in diagnostic capabilities.
- Pharmaceutical & Biotech Companies : Companies developing infectious disease treatments require Italian market data to understand diagnostic adoption rates, identify partnership opportunities, and align product development with market needs.
- Healthcare Consultants & Advisors : Consulting firms advising Italian healthcare organizations need comprehensive market data to provide strategic recommendations on diagnostic service expansion and technology adoption strategies.
Key Companies in the Italy Infectious Disease Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|
Reasons to Buy this Report
- Italy-Specific Market Sizing : Access precise market valuation data for Italy ($537.6M in 2025) with detailed forecasts through 2030, enabling accurate business planning and investment decisions for the Italian market.
- Competitive Landscape Intelligence : Understand Italy's unique competitive dynamics, local player strategies, and market consolidation trends specific to the Italian infectious disease diagnostics sector.
- Growth Driver Analysis : Identify key growth catalysts in Italy including healthcare infrastructure investments, regulatory changes, and disease prevalence patterns driving the 8.9% CAGR expansion.
- Regional Market Segmentation : Gain insights into Italy's regional diagnostic market variations, healthcare spending patterns, and geographic opportunities across different Italian healthcare systems.
- Strategic Market Entry Planning : Develop informed market entry or expansion strategies for Italy with comprehensive data on customer needs, reimbursement frameworks, and distribution channels specific to Italian healthcare.
Frequently asked questions
What is the current size of Italy's infectious disease diagnostics market?
Italy's infectious disease diagnostics market is valued at $537.6 million in 2025.
What is the projected market size for Italy by 2030?
Italy's infectious disease diagnostics market is projected to reach $822.9 million by 2030.
What is the CAGR for Italy's infectious disease diagnostics market?
Italy's infectious disease diagnostics market is expected to grow at a compound annual growth rate of 8.9% from 2025 to 2030.
What factors are driving growth in Italy's infectious disease diagnostics market?
Key drivers include Italy's aging population, rising infectious disease prevalence, increased healthcare spending, and adoption of advanced diagnostic technologies.
How does Italy's market growth compare to global trends?
Italy's 8.9% CAGR is slightly below the global average of 9.7%, reflecting regional market maturity and competitive dynamics specific to the Italian healthcare system.
RESEARCH METHODOLOGY
The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. The objectives include tracking company developments such as acquisitions, product/service launches & approvals, expansions, agreements, and partnerships of the leading players. These parameters were evaluated on various parameters within the broad business & product strategy categories. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify & collect information for this study.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative & quantitative information for this report. Primary sources included experts from the core & related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain & verify critical qualitative & quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| Abbott (US) | Sales Manager |
| Becton, Dickinson and Company (US) | Product Manager |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the infectious disease diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the infectious disease diagnostics market have been determined through primary & secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Infectious disease diagnostics can be defined as various techniques and products (including kits, assays, tests, reagents, and analyzers) used by healthcare professionals to detect and diagnose disease-causing pathogens in human samples such as serum, blood, urine, throat swabs, and stool, among others.
Stakeholders
- Manufacturers & distributors of infectious disease diagnostics
- IVD companies
- Hospitals & clinics
- Academic research institutes
- Diagnostic laboratories
- Blood banks
- Home health agencies
- Market research & consulting firms
- Government associations
- Venture capitalists & investors
Report Objectives
- To define, describe, segment, and forecast the global infectious disease diagnostics market by product & service, type of testing, sample type, disease type, technology, clinical application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall infectious disease diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the infectious disease diagnostics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Get the Full Infectious Disease Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Infectious Disease Diagnostics Market.
- US Infectious Disease Diagnostics Market
- Canada Infectious Disease Diagnostics Market
- Germany Infectious Disease Diagnostics Market
- UK Infectious Disease Diagnostics Market
- France Infectious Disease Diagnostics Market
- Spain Infectious Disease Diagnostics Market
- China Infectious Disease Diagnostics Market
- Japan Infectious Disease Diagnostics Market
- India Infectious Disease Diagnostics Market
- Brazil Infectious Disease Diagnostics Market
- Mexico Infectious Disease Diagnostics Market
- United Arab Emirates Infectious Disease Diagnostics Market
- Rest Of Europe Infectious Disease Diagnostics Market
- Rest Of Asia Pacific Infectious Disease Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report